COVID-19 mRNA vaccine (GreenLight Biosciences)

N/A

Report date: 2026/05/13 11:17:55

Base Information

Drug NameCOVID-19 mRNA vaccine (GreenLight Biosciences)

Drug Alias NameGLB-COV2-043

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGreenlight Biosciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGreenlight Biosciences

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A